Publications by authors named "Mitchell Cairo"

Claim this Profile
C
CXCL10-induced chemotaxis of -expanded natural killer cells combined with NKTR-255 enhances anti-tumor efficacy in osteosarcoma.
Shiori Eguchi, Wen Luo, Hongwen Zhu, Hai M Hoang, Changxin Xu, Mitchell S Cairo

Mol Ther Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in augmenting infiltration of active natural killer cells into pediatric and adult solid tumors.
Shiori Eguchi, Wen Luo, Hongwen Zhu, Jeremy M Rosenblum, Anna R Cooper, Mitchell S Cairo

Mol Ther Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent Epstein-Barr virus viremia in NK-/T-cell lymphoma: bad boys for life!
Ana C Xavier, Yanling Liao, Mitchell S Cairo

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory modulation by cord blood stem cells prevented digit deformation in recessive dystrophic epidermolysis bullosa.
Morgan Anderson-Crannage, Alexander Nyström, Rahim Hirani, Edo Schaefer, Bruno Hochberg, Mitchell S Cairo

Mol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rasburicase vs. allopurinol: mortality in hematological malignancies post anti-hyperuricemic therapy - real-world study.
Mitchell Stuart Cairo, Jack Ray Gallagher, Yvonne Barnes, Edward Drea, Christopher Clark

Support Care Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD19 CAR T-Cell Therapy for Primary Mediastinal Large B-Cell Lymphoma: A CIBMTR Analysis.
Jordan Gauthier, Kwang W Ahn, Jinalben Patel, Qinghua Lian, Sherif Badawy, Mitchell S Cairo

Am J Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted immunotherapy in the treatment of childhood and adolescent mature B-cell lymphoma.
Anthony N Audino, Aliza Gardenswartz, Mitchell S Cairo

Clin Adv Hematol Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knockout of IL-1R1 Reduced Inflammation and Improved Survival in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa.
Morgan Anderson-Crannage, Rahim Hirani, Jian Pan, Mishel Ramirez, Meijuan Tian, Mitchell S Cairo

J Invest Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in Observed Outcomes and Toxicities for Adolescent and Young Adult Patients With Aggressive Mature B-Cell Lymphomas Treated at an Adult Versus Pediatric Cancer Center.
Allison M LeHanka, Ann M Kebede, Neda Amirmokhtari, Joseph R Stanek, Faye Willen, Mitchell S Cairo

Pediatr Blood Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR-NK's balancing act: when scFv affinity is not too tight, not too loose… but just right?
Yanling Liao, Mitchell S Cairo

J Immunother Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitoxantrone in combination with clofarabine (MITCL) in children, adolescents and young adults with relapsed/refractory acute leukaemia: final results of a phase I/II trial.
Jessica Hochberg, Javier Oesterheld, Aliza Gardenswartz, Allyson Flower, Liana Klejmont, Mitchell S Cairo

EClinicalMedicine· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma.
Yaya Chu, Meijuan Tian, Uksha Saini, Jessica Ayala-Cuesta, Kayleigh Klose, Mitchell S Cairo

Mol Ther Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial immunotherapy of anti-MCAM CAR-modified expanded natural killer cells and NKTR-255 against neuroblastoma.
Wen Luo, Aliza Gardenswartz, Hai Hoang, Yaya Chu, Meijuan Tian, Mitchell S Cairo

Mol Ther Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reading through the nonsense: Gentamicin and ELX-02 as rescuing therapies for epidermolysis bullosa.
Morgan Anderson-Crannage, Mitchell S Cairo, Yanling Liao

Mol Ther Nucleic Acids· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted immunotherapy in the treatment of childhood and adolescent classic Hodgkin lymphoma.
Ana C Xavier, Jessica Hochberg, Mitchell S Cairo

Clin Adv Hematol Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
binding domain mutations are bad news in Burkitt lymphoma.
Mitchell S Cairo

Haematologica· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circumventing resistance within the Ewing sarcoma microenvironment by combinatorial innate immunotherapy.
Wen Luo, Hai Hoang, Hongwen Zhu, Katherine Miller, Xiaokui Mo, Mitchell S Cairo

J Immunother Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning "Two Keys" simultaneously.
Wen Luo, Hai Hoang, Katherine E Miller, Hongwen Zhu, Serena Xu, Mitchell S Cairo

J Exp Clin Cancer Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors.
Siddhi N Paudel, Brian J Hutzen, Katherine E Miller, Elizabeth A R Garfinkle, Chun-Yu Chen, Mitchell S Cairo

Front Immunol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors.
Siddhi N Paudel, Brian J Hutzen, Katherine E Miller, Elizabeth A R Garfinkle, Chun-Yu Chen, Mitchell S Cairo

Front Immunol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma in Children, Adolescents, and Young Adults.
Aliza Gardenswartz, Mitchell S Cairo

J Natl Compr Canc Netw· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 and in NB xenografts.
Yaya Chu, Gaurav Nayyar, Meijuan Tian, Dean A Lee, Mehmet F Ozkaynak, Mitchell S Cairo

Mol Ther Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clinical trial.
Suzanne Braniecki, Elliott Vichinsky, Mark C Walters, Shalini Shenoy, Qiuhu Shi, Mitchell S Cairo

Front Neurol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A humanized orthotopic mouse model for preclinical evaluation of immunotherapy in Ewing sarcoma.
Wen Luo, Hai Hoang, Yanling Liao, Jian Pan, Janet Ayello, Mitchell S Cairo

Front Immunol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin.
Morgan Anderson-Crannage, Alex M Ascensión, Olga Ibanez-Solé, Hongwen Zhu, Edo Schaefer, Mitchell S Cairo

Front Immunol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis